ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 简式权益变动报告书 | 2024-12-13 | Chinese | |
| 2024年度向特定对象发行股票方案的论证分析报告 | 2024-12-13 | Chinese | |
| 第六届监事会第三次会议决议公告 | 2024-12-13 | Chinese | |
| 关于公司董事长收到《撤销案件决定书》的公告 | 2024-12-13 | Chinese | |
| 关于持股5%以上股东协议转让股份过户完成的公告 | 2024-12-13 | Chinese | |
| 关于拟变更会计师事务所的公告 | 2024-12-09 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 36042695 | 简式权益变动报告书 | 2024-12-13 | Chinese | ||
| 36042682 | 2024年度向特定对象发行股票方案的论证分析报告 | 2024-12-13 | Chinese | ||
| 36042673 | 第六届监事会第三次会议决议公告 | 2024-12-13 | Chinese | ||
| 36042661 | 关于公司董事长收到《撤销案件决定书》的公告 | 2024-12-13 | Chinese | ||
| 36042651 | 关于持股5%以上股东协议转让股份过户完成的公告 | 2024-12-13 | Chinese | ||
| 36042646 | 关于拟变更会计师事务所的公告 | 2024-12-09 | Chinese | ||
| 36042634 | 第六届董事会第二次会议决议公告 | 2024-12-09 | Chinese | ||
| 36042629 | 第六届监事会第二次会议决议公告 | 2024-12-09 | Chinese | ||
| 36042614 | 关于召开2024年第三次临时股东会的通知 | 2024-12-09 | Chinese | ||
| 36042599 | 关于睿智医药科技股份有限公司前期会计差错更正专项说明的鉴证报告 | 2024-11-29 | Chinese | ||
| 36042591 | 关于回购股份注销完成暨股份变动的公告 | 2024-11-26 | Chinese | ||
| 36042580 | 关于注销回购股份减少注册资本暨通知债权人的公告 | 2024-11-14 | Chinese | ||
| 36042567 | 第六届监事会第一次会议决议公告 | 2024-11-14 | Chinese | ||
| 36042560 | 第六届董事会第一次会议决议公告 | 2024-11-14 | Chinese | ||
| 36042552 | 关于董事会、监事会换届完成并聘任高级管理人员及其他人员的公告 | 2024-11-14 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.